We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.05B
AUM Growth
-$2.89B
Cap. Flow
-$2.96B
Cap. Flow %
-281.28%
Top 10 Hldgs %
16.51%
Holding
1,419
New
160
Increased
195
Reduced
212
Closed
815

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$19.4M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$19.4M
3
MON
Monsanto Co
MON
+$17.8M
4
ECL icon
Ecolab
ECL
+$17.1M
5
VC icon
Visteon
VC
+$13M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$69.1M
2
GILD icon
Gilead Sciences
GILD
+$59.1M
3
MRK icon
Merck
MRK
+$54.1M
4
WFC icon
Wells Fargo
WFC
+$53.8M
5
X
US Steel
X
+$52.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.13%
2 Technology 13.74%
3 Healthcare 12.34%
4 Financials 12.02%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
651
AstraZeneca
AZN
$263B
– –
-5,206
Closed -$372K
BAH icon
652
Booz Allen Hamilton
BAH
$8.77B
– –
-46,026
Closed -$1.08M
BAP icon
653
Credicorp
BAP
$31B
– –
-45,326
Closed -$6.95M
BCE icon
654
BCE
BCE
$19.9B
– –
-21,959
Closed -$939K
BCH icon
655
Banco de Chile
BCH
$20.9B
– –
-28,671
Closed -$644K
BCO icon
656
Brink's
BCO
$4.89B
– –
-41,247
Closed -$992K
BCRX icon
657
BioCryst Pharmaceuticals
BCRX
$2.49B
– –
-70,474
Closed -$689K
BEN icon
658
Franklin Resources
BEN
$17.2B
– –
-9,700
Closed -$530K
BFS
659
Saul Centers
BFS
$884M
– –
-6,485
Closed -$303K
BG icon
660
Bunge Global
BG
$22.8B
– –
-110,880
Closed -$9.34M
BGC icon
661
BGC Group
BGC
$5.59B
– –
-95,322
Closed -$455K
BGS icon
662
B&G Foods
BGS
$292M
– –
-13,077
Closed -$360K
BHP icon
663
BHP
BHP
$211B
– –
-181,755
Closed -$9.05M
BHR
664
Braemar Hotels & Resorts
BHR
$156M
– –
-15,836
Closed -$239K
BIO icon
665
Bio-Rad Laboratories Class A
BIO
$8.55B
– –
-15,472
Closed -$1.75M
BKH icon
666
Black Hills Corp
BKH
$5.7B
– –
-12,034
Closed -$576K
BKNG icon
667
Booking.com
BKNG
$145B
– –
-32,500
Closed -$1.51M
BKU icon
668
Bankunited
BKU
$3.38B
– –
-15,045
Closed -$459K
BLK icon
669
Blackrock
BLK
$164B
– –
-38,447
Closed -$12.6M
BNS icon
670
Scotiabank
BNS
$106B
– –
-160,828
Closed -$9.32M
BOH icon
671
Bank of Hawaii
BOH
$3.19B
– –
-11,400
Closed -$648K
BP icon
672
BP
BP
$110B
– –
-117,781
Closed -$4.23M
BPOP icon
673
Popular Inc
BPOP
$11B
– –
-34,944
Closed -$1.03M
BRFS
674
DELISTED
BRF SA
BRFS
– –
-16,400
Closed -$390K
BRKR icon
675
Bruker
BRKR
$9.16B
– –
-14,046
Closed -$260K
25 26
27
28 29

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q4 2014 Portfolio in Review

As of Q4 2014, PDT Partners held 1,419 positions worth $1.05B, down 73% from $3.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

PDT Partners withdrew a net $2.96B in Q4 2014, closing 815 positions and reducing 212 holdings. Its most notable exit was Gilead Sciences, an estimated $59.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PDT Partners opened a new position in Baxter International worth $19.8M.

  • PDT Partners's largest Q4 2014 buy was Baxter International: 498,449 shares worth $19.8M.
  • PDT Partners added most to Visteon in Q4 2014, an estimated $13M increase.
  • PDT Partners's biggest Q4 2014 reduction was Yahoo Inc, cutting an estimated $69.1M.
  • PDT Partners fully exited Gilead Sciences in Q4 2014, selling an estimated $59.1M.
  • PDT Partners's ten largest holdings make up 17% of its $1.05B portfolio in Q4 2014.
  • PDT Partners opened 160 new positions and closed 815 in Q4 2014.
  • PDT Partners's portfolio value fell 73% quarter-over-quarter to $1.05B.

Based on PDT Partners's 13F filing for Q4 2014, filed 17 Feb 2015.